Table 2.

cGVHD characteristics based on the aGVHD response

	No aGVHD (n = 78)	SS aGVHD (n = 31)	SD aGVHD (n = 48)	Steroid-refractory aGVHD (n = 41)	Total (n = 198)
cGVHD onset
De novo	78 (100%)	0 (0%)	0 (0%)	0 (0%)	77 (39%)
Quiescent	0 (0%)	25 (81%)	29 (60%)	25 (62%)	79 (40%)
Progressive	0 (0%)	6 (19%)	19 (40%)	15 (38%)	41 (21%)
cGVHD type
Classic	54 (69%)	17 (55%)	31 (66%)	25 (62%)	127 (65%)
Overlap	24 (31%)	14 (45%)	16 (34%)	15 (38%)	69 (35%)
cGVHD severity
Mild	12 (15%)	6 (19%)	11 (23%)	6 (15%)	35 (18%)
Moderate	50 (64%)	18 (58%)	27 (57%)	22 (55%)	117 (60%)
Severe	16 (21%)	7 (23%)	9 (19%)	12 (30%)	44 (22%)

SD has 1 unknown type and severity. Steroid refractory has 1 unknown onset, type, and severity.